Press Releases
February 5, 2026
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more effectively.
February 3, 2026
The innovative approach could significantly shorten and simplify HIV vaccination protocols, making them more accessible worldwide.
January 29, 2026
Research reveals molecule acts as an immune-system amplifier, boosting the body’s inflammatory defenses during early infection but elevating them to deadly levels when infections progress to sepsis.
January 26, 2026
Board of Trustees conducting president & CEO search process
January 13, 2026
Xu specializes in antibody research & engineers nanobodies—tiny, effective tools against HIV & emerging pandemics
December 16, 2025
PRESS RELEASE CONTACT: Darien Sutton 215-898-3988 | dsutton@wistar.org The State’s only National Cancer Institute-designated Basic Cancer Center, this is the third consecutive “Exceptional” rating…
December 3, 2025
Interdisciplinary scientist brings expertise in molecular biology and bioinformatics to study HIV reservoir, where dormant virus hides
November 24, 2025
Grant will support training opportunities for nontraditional students, from community college to adults living and learning in Philadelphia
November 11, 2025
PRESS RELEASE CONTACT: Darien Sutton 215-898-3988 | dsutton@wistar.org PHILADELPHIA — (Nov. 11, 2025) — On Monday, Nov. 17th at 6:30 pm EST, Richard Jefferys, Basic Science, Vaccines and Cure Proje…
November 11, 2025
Wistar scientists have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy often fails even when tumors express the hormone receptor that should make them responsive.









